Your browser doesn't support javascript.
loading
Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF).
Van Niel, A; Zacks, S E; David, J R; Remold, H G; Weiser, W Y.
Afiliação
  • Van Niel A; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Adv Exp Med Biol ; 239: 231-7, 1988.
Article em En | MEDLINE | ID: mdl-3059767
ABSTRACT
A non-interferon lymphokine elaborated from PHA and Con A-stimulated human T-cell hybridoma, T-CEMA, has been found to activate monocyte-derived macrophages for the intracellular killing of L. donovani (antileishmanial MAF). This T-cell hybridoma derived antileishmanial MAF which has an apparent mw of 65,000 and pI of 5.3-5.6, contains neither antiviral activity nor colony stimulating activity. Furthermore, antileishmanial MAF is not neutralized by anti-MIF, anti-IFN-gamma or anti-GM-CSF antibodies.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Leishmania donovani / Linfocinas / Ativação de Macrófagos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 1988 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Leishmania donovani / Linfocinas / Ativação de Macrófagos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 1988 Tipo de documento: Article